Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Locally Advanced Rectal Cancer × Radiation × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 28 Glioblastoma 23 Breast Neoplasms 18 Lung Neoplasms 17 Carcinoma, Non-Small-Cell Lung 13 Oropharyngeal Neoplasms 12 Squamous Cell Carcinoma of Head and Neck 10 Gliosarcoma 9 Urinary Bladder Neoplasms 8 Brain Neoplasms 8 Uterine Cervical Neoplasms 7 Melanoma 7 Esophageal Neoplasms 7 Sarcoma 6 Mouth Neoplasms 6 Head and Neck Neoplasms 6 Glioma 6 Astrocytoma 6 Triple Negative Breast Neoplasms 5 Rectal Neoplasms 5 Pancreatic Neoplasms 5 Carcinoma, Squamous Cell 5 Adenocarcinoma Of Esophagus 5 Neoplasms 4 Neoplasm Metastasis 4 Laryngeal Neoplasms 4 Esophageal Squamous Cell Carcinoma 4 Carcinoma, Hepatocellular 4 Carcinoma 4 Adenocarcinoma of Lung 4

Interventions

Capecitabine 7 Oxaliplatin 5 Fluorouracil 3 tislelizumab 2 spartalizumab 2 Leucovorin 2 Irinotecan 2 toripalimab 1 sintilimab 1 irinotecan sucrosofate 1 camrelizumab 1 Thymalfasin 1 Radiotherapy, Intensity-Modulated 1 Radiation 1 Folfox protocol 1 Celecoxib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06493240 2025-11-25

NLCCRIT-LARC

Peking University People's Hospital

Phase 2 Completed

Gastrointestinal

Locally Advanced Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡